Paper38136282
Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer.
Lideståhl A and 4 others. Cancers (Basel), 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer. Papers, record 38136282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22 2052 S 01 H | Swedish Cancer Society | PubMed | ||
| RS2021-0855 | Region Stockholm | PubMed | ||
| 171193 | Radium Hemmets Research Funds | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23165743 | Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. | Cancer | 2013 | https://conductscience.org/library/papers/23165743 | PubMed |
| 2 | 36990633 | Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations. | Semin Radiat Oncol | 2023 | https://conductscience.org/library/papers/36990633 | PubMed |
| 3 | 30777251 | Palliation of Vertebral Metastases with Radiotherapy: Exploration of Volumetric-Modulated Arc Therapy From Development to Implementation in Routine Clinical Practice. | J Med Imaging Radiat Sci | 2019 | https://conductscience.org/library/papers/30777251 | PubMed |
| 4 | 30114534 | Predominance of Spinal Metastases Involving the Posterior Vertebral Body. | World Neurosurg | 2018 | https://conductscience.org/library/papers/30114534 | PubMed |
| 5 | 35616646 | Volumetric modulated arc therapy (VMAT): a review of clinical outcomes-what is the clinical evidence for the most effective implementation? | Br J Radiol | 2022 | https://conductscience.org/library/papers/35616646 | PubMed |
| 6 | 36958590 | Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36958590 | PubMed |
| 7 | 34126044 | Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/34126044 | PubMed |
| 8 | 35661676 | ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases. | Radiother Oncol | 2022 | https://conductscience.org/library/papers/35661676 | PubMed |
| 9 | 22571913 | Range uncertainties in proton therapy and the role of Monte Carlo simulations. | Phys Med Biol | 2012 | https://conductscience.org/library/papers/22571913 | PubMed |
| 10 | 17668947 | Dosimetry aspects of proton therapy. | Technol Cancer Res Treat | 2007 | https://conductscience.org/library/papers/17668947 | PubMed |
| 11 | 30849005 | Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives. | J Oncol Pract | 2019 | https://conductscience.org/library/papers/30849005 | PubMed |
| 12 | 32757820 | Conventional Radiotherapy and Stereotactic Radiosurgery in the Management of Metastatic Spine Disease. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/32757820 | PubMed |
| 13 | 35935707 | Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study. | Tech Innov Patient Support Radiat Oncol | 2022 | https://conductscience.org/library/papers/35935707 | PubMed |
| 14 | 37079324 | Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/37079324 | PubMed |
| 15 | 34623944 | Fundamentals of Radiation Oncology for Treatment of Vertebral Metastases. | Radiographics | 2021 | https://conductscience.org/library/papers/34623944 | PubMed |
| 16 | 26699573 | Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study. | J Appl Clin Med Phys | 2015 | https://conductscience.org/library/papers/26699573 | PubMed |
| 17 | 29511626 | Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data. | J Bone Oncol | 2018 | https://conductscience.org/library/papers/29511626 | PubMed |
| 18 | 20483155 | Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). | J Urol | 2010 | https://conductscience.org/library/papers/20483155 | PubMed |
| 19 | 24885766 | Radiotherapy in patients with distant metastatic breast cancer. | Radiat Oncol | 2014 | https://conductscience.org/library/papers/24885766 | PubMed |
| 20 | 22863464 | Proton facility economics: the importance of "simple" treatments. | J Am Coll Radiol | 2012 | https://conductscience.org/library/papers/22863464 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136282
GET https://conductscience.org/api/papers/v1/38136282/references?page=2